Hikma Pharmaceuticals Forum

Nearly 30% off year high - Directors buying like candy - income in $ - WTF?

Columbus site is failing. Boehringer sold it for a reason, it now seems. Mass exodus of technical staff and no filings but one or two out of 16 promised.

Welcome to the new Hikma Pharmaceuticals stream forum! Messages posted in the Hikma Pharmaceuticals stream will be logged here for posterity.

"The past year has been a turbulent one for Hikma. A shortage-fuelled growth spurt and a resulting guidance upgrade had heralded the Jordanian company’s entry into the FTSE 100 in March 2015 (following the c.25% rally since the beginning of the year), making it only the fourth pharma constituent to become a component of this ‘blue-chip’ index. Fast forward a year, however, and multiple downgrades later, investor enthusiasm towards the company had waned, resulting in the stock being kicked out of the index in March 2016." AlphaValue's view on research tree...